Great West Life Assurance CO Cassava Sciences Inc Transaction History
Great West Life Assurance CO
- $58 Billion
- Q4 2024
A detailed history of Great West Life Assurance CO transactions in Cassava Sciences Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 11,380 shares of SAVA stock, worth $29,588. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,380
Previous 3,814
198.37%
Holding current value
$29,588
Previous $112,000
75.89%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding SAVA
# of Institutions
190Shares Held
16.4MCall Options Held
3.49MPut Options Held
8.08M-
Black Rock Inc. New York, NY3.22MShares$8.37 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$6.54 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$2.62 Million0.0% of portfolio
-
State Street Corp Boston, MA997KShares$2.59 Million0.0% of portfolio
-
Ubs Group Ag931KShares$2.42 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $104M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...